Cerevel Therapeutics Hldng I shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Cerevel Therapeutics Hldng I
Tip: Access up to 7 years of quarterly data
All positions including Cerevel Therapeutics Hldng I held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cerevel Therapeutics Hldng I by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.6M | 37k | 42.40 |
| 2023-09-30 | $716k | 33k | 21.83 |
| 2023-06-30 | $1.0M | 33k | 31.79 |
| 2023-03-31 | $742k | 30k | 24.39 |
| 2022-12-31 | $959k | 30k | 31.54 |
| 2022-09-30 | $815k | 29k | 28.26 |
| 2022-06-30 | $763k | 29k | 26.44 |
| 2022-03-31 | $881k | 25k | 35.01 |
| 2021-12-31 | $515k | 16k | 32.42 |
| 2021-09-30 | $468k | 16k | 29.50 |
| 2021-06-30 | $407k | 16k | 25.62 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors